PHA-301. & 304. Foundations of Pharmacy Practice I and II
The purpose of this two-semester course is to provide the student with the foundational knowledge, skills and attitudes needed to practice pharmacy in the 21st century. In particular, this course will focus on skills (communication, teamwork), attitudes and other content relevant to the practice of pharmacy. The school’s team-focused approach to learning is emphasized throughout. This course fulfills experiential requirements and so students will have the opportunity to interact with pharmacists and patients. Requirement: P-1 standing.
PHA-302. , 401, 402, 501, & 502. Pharmacy Care Lab I - V
This five-semester sequence is designed to develop the student's ability to integrate and apply information as well as practice skills that are taught throughout the curriculum. The use of case studies, role-plays, presentations, and other active-learning strategies engages students in the learning process and requires them to synthesize information at increasing levels of complexity as the student moves through the course sequence. Requirement: P-1, P-2, or P-3 standing, as appropriate for each laboratory.
PHA-308. Pharmaceutical and Health Care Delivery
Examination of health and pharmaceutical delivery in the U.S. conducted from a societal perspective. Emphasis is on public policy, economic behavior, and outcomes. Application will be made to various pharmaceutical sectors (e.g., retail, health, systems, manufacturing). Students should gain an understanding of the factors driving transformation of health care delivery and the implications for future pharmacy practice. Lecture: three hours per week. Requirement: P-1 standing or consent of the instructor. Cross-listed with PHS-308.
PHA-310. Clinical Research and Design
In order to apply current research to patient care activities, one must first develop the skills to interpret studies. The purpose of this course is to learn how research studies are designed to answer specific clinical questions, and how the study design is important in interpreting the results of the studies. Students will apply research design concepts and statistical techniques to design, critically analyze, and interpret preclinical, clinical, and economic studies of pharmaceuticals and treatment plans. Lecture: three hours per week.
PHA-311. & PHA 312 Pharmaceutics I & II
The study and application of physical-chemical principles that are necessary for the design, development, and preparation of pharmaceutical dosage forms. The study of quantitative skills necessary for an understanding of the basic and clinical pharmaceutical sciences, including skills in pharmaceutical calculations and extemporaneous preparation of dosage forms. lecture: three hours per week. Laboratory and Recitation: three hours per week. Requirement: P-1 standing or consent of the instructor. NOTE: PHA-311 is a prerequisite for PHA-312.
PHA-313. Pharmacy Calculations
The common mathematical processes that a pharmacist may encounter in professional practice are covered. Interpretation of the prescription, including Latin abbreviations, will be discussed. Medical terminology and the generic name, trade name, manufacturer, and classification of the top 100 drugs will also be presented. Lecture one hour per week. Requirement: P-1 standing or permission of the instructor.
PHA-327. Medical Microbiology
An overview of microbiology with special emphasis on pathogenic microbiology. Lecture: three hours per week. Requirement: P-1 standing or consent of the instructor. Cross listed with [[PHS 327]].
PHA-331. & 332. Medical Anatomy and Physiology I & II
In-depth principles of human anatomy and physiology as well as an introduction to pathophysiology will be presented. Lecture: Two hours per week. Recitation and Lab: two hours per week. Requirement: P-1 standing or consent of the instructor. This course is restricted to enrolled Pharmacy students. Consideration may be given to non-pharmacy students with overall GPAs of 3.0 or greater, if there is room in the lecture and lab sessions, and with instructor approval. NOTE: PHA 331 is a prerequisite for PHA 332.
PHA-335. Introductory Pharmacy Practice Experience I
This course will provide introductory practice experience to students in the community setting. The course fosters the development of professionalism in an environment of practical application of knowledge, skills, and attitudes. Students will be faced with a variety of issues practical to community pharmacy. The student will take an independent learning approach under the supervision of a practicing community pharmacist. The course is two full-time weeks (80 hours) of experience.
PHA-360. Self-Directed IPPE I
The Self-Directed (SD)-IPPE program is made up of three courses (SD-IPPE I, II, and
III) over the span of the Pl through P3 years. Collectively these courses consist
of a total of 20 hours of pharmacy-related, service-oriented learning.
The Self-Directed Introductory Pharmacy Practice Experience (SD- IPPE) course is designed
to expose students to various service-learning opportunities throughout their P 1
through P3 years. This experience consists of three components: participation in and
development of service- learning projects, reflection, and self-directed learning.
Students may develop their own experiences or participate in opportunities offered
by the School or professional organizations.
Requirements for service learning hours will increase as the student progresses through
the curriculum. Each student must complete a minimum of 2, 8, and 10 hours during
the Pl, P2, and P3 years, respectively (total 20 hours). Additional details are provided
in the SDIPPE syllabus conveniently posted in E*Value.
PHA-365. Medical Biochemistry
Introduction to basic biochemistry concepts, focusing on the structure and function of vitamins, proteins, and lipids as well as bioenergetics and major catabolic pathways. The catabolism of carbohydrates, fats and amino acids will be discussed including reactions and regulation. Common metabolic pathways of drugs, enzyme induction and metabolism down regulation will also be presented. Lecture: Four hours per week. Cross-listed with CHM-365, BEGR-465.
PHA-405. Pharmaceutical Care Systems: Design and Control
Examines delivery of pharmaceutical products and services from a systems perspective in a variety of patient care settings. Focus is upon effectiveness, efficiency, and quality. Covers design of systems, establishment and monitoring of key indicators, total quality management, and quality assurance agencies (e.g., JCAHO, NCQA). Lecture: two hours per week.
PHA-410. Immunology and Biotechnology
A discussion of nonspecific host defense mechanisms and a detailed description of specific immunity. Products that impart artificial active and passive immunity are presented. The concept of biotechnology is discussed together with the currently available products of genetic engineering that relate to immunology. The various immunological disorders and the immunology of cancer and HIV are discussed. Lecture: three hours per week.
PHA-411. Biopharmaceutics and Clinical Pharmacokinetics
Biopharmaceutics and Clinical Pharmacokinetics is designed to educate pharmacy students in the principles of pharmacokinetics and biopharmaceutics and how they assist in dosage regimen design and therapeutic efficacy evaluations. The impact of the physical and chemical forms nature of the drug and dosage forms will be studied as they relate to the absorption, distribution, metabolism, and elimination. The clinical pharmacokinetics of individual drugs will be examined with emphasis on clinical application based on patient presentations. Case studies, homework, and quizzes will be used to facilitate student learning. This course is roughly divided into two parts. The first is Biopharmaceutics/ Pharmacokinetics and the second is Clinical Pharmacokinetics. Lecture: three hours per week.
PHA-412. Management of Pharmacy Operations
The principles of management, including personnel and financial management, will be covered as they apply to management of pharmacy operations in a variety of settings (e.g., community, health system, managed care). Lecture: three hours per week.
PHA-421. Pharmacotherapeutics I: Principles of Pharmacology & Medicinal Chemistry
This course is the 1st of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This particular course will emphasize the most fundamental concepts central to drug therapy. A major emphasis will be placed on the interactions of drugs with their cellular targets in the human body, and the chemical properties of drugs that dictate their biological activity.
PHA-423. Pharmacotherapeutics II: Principles of Pharmacotherapeutics
This course is the 2nd of a twelve module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for understanding Pharmacotherapeutics principles.
PHA-425. Pharmacotherapeutics III: Self-Care and Dermatology*
This course is the 3rd of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of dermatological disorders and self- care issues.
PHA-426. Pharmacotherapeutics IV: Gastrointestinal Disorders*
This course is the 6th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of gastrointestinal diseases.
PHA-428. Pharmacotherapeutics V: Infectious Diseases*
This course is the 4th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of infectious diseases.
PHA-430. Pharmacotherapeutics VI: Joint, Autoimmune and Musculoskeletal Disorders
This course is the 5th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of joint, autoimmune and musculoskeletal diseases.
PHA-435. Pharmacogenomics
Students will learn to understand how human genetics and genomics can be used to provide optimized drug therapy and patient care. Learning about this emerging field will enable students to better understand and manage new genomics-based diagnostic tools and make personalized treatment choices. Students will also spend time discussing societal and ethical implications of genetic testing and the resultant individualization of drug therapy, explain basic principles of human genetics and heredity, and more. Requirement: P-3 standing.
PHA-440. Introductory Pharmacy Practice Experience II
This course will provide introductory practice experience to students in two health care settings: prescriber’s clinics and a clinical pharmacy site. Students will have an independent approach to learning and gain a broader understanding of these settings and the role that pharmacists may play. Requirement: Successful completion of all required courses in the P-1 year, or permission of instructor.
PHA-445. Introductory Pharmacy Practice Experience III
This course will provide introductory practice experience to students in the health-system setting. The course fosters the development of professionalism in an environment of practical application of knowledge, skills, and attitudes. Students will be faced with a variety of issues practical to this area of practice. The student will take an independent learning approach under the supervision of a practicing community pharmacist. The course is two full-time weeks (80 hours) of experience. Requirement: Successful completion of all required courses in P-2 year, or permission of instructor.
PHA-450. Neuropharmacology of Drugs of Abuse
In-depth analysis of drugs of abuse, including pharmacokinetics, pharmacodynamics, tolerance, sensitization, physical dependence, and effects of drug use during pregnancy. Drug testing and substance abuse treatment strategies will also be discussed. Lecture: three hours.
PHA-452. Extemporaneous Compounding
Students will achieve basic and advanced skills in compounding pharmaceutical dosage forms for individualized patient therapy to replace a lack of commercially available products and enhance therapeutic problem-solving between the pharmacist and physician to enhance patient compliance. Students will work independently on research assignments and compounding preparations. Lecture: one hour per week. Lab: six hours per week.
PHA-456. Concepts in Primary Care
The course is designed to allow students to explore and develop advanced knowledge and skills related to diseases and medications commonly encountered in a primary care environment. This course will be of value to pharmacy students seeking careers in ambulatory care pharmacy practice, community pharmacy, long-term care and population health management. Topics are presented in a case-based discussion format that includes multiple diseases and medications and through student-led mini topic discussions.
PHA-460. Self-Directed IPPE II
The Self-Directed (SD)-IPPE program is made up of three courses (SD-IPPE I, II, and
III) over the span of the Pl through P3 years. Collectively these courses consist
of a total of 20 hours of pharmacy-related, service-oriented learning.
The Self-Directed Introductory Pharmacy Practice Experience (SD- IPPE) course is designed
to expose students to various service-learning opportunities throughout their P 1
through P3 years. This experience consists of three components: participation in and
development of service- learning projects, reflection, and self-directed learning.
Students may develop their own experiences or participate in opportunities offered
by the School or professional organizations.
Requirements for service learning hours will increase as the student progresses through
the curriculum. Each student must complete a minimum of 2, 8, and 10 hours during
the Pl, P2, and P3 years, respectively (total 20 hours). Additional details are provided
in the SDIPPE syllabus conveniently posted in E*Value.
PHA-461. Cannabis Law and Policy
PHA-462. Hemp Biology and Analysis
This course is an introduction to hemp biology and analysis. Topics include an overview
of hemp, hemp phylogeny, subspecies, plant structure, development, reproduction,
water uptake, transport, uses for hemp, hemp pathogens and pests, and ways to improve
hemp production using biotechnology.
Click here for course fee.
PHA-463. Cannabis and Cannabinoids
PHA-465. Therapeutics of Medicinal Cannabis
and cachexia in cancer patients, emesis, pain, migraines, muscle spasticity disorders, movement
disorders, glaucoma, gynecology, dermatology, and the cardiovascular system. This course will also
cover the risks and side effects, from a clinical perspective, of cannabis use during pregnancy, to the
immune system, psyche and cognition, and the respiratory system.
PHA-466. Cannabis/CBD Extraction Capstone Project Seminar
Program to engage in research and demonstrate competencies in Cannabis law, concentration,
extraction and use of cannabis products. The students will be given the opportunity to collect data,
initiate a lab experiment or analyze a potential use for cannabis, and determine the impact of the
initiative on cannabis production, extraction, health care, local communities, global communities and
cannabis use in the US.
courses
PHA-488 . Aspects of Caring for the Pain Patient
This course is an interactive and interprofessional approach to the assessment and management of pain. Various teaching and learning strategies will allow students to develop and appreciate the understanding of the social, psychological, physical, spiritual and ethical implications of pain.
PHA-505. Pharmacy Law
The study of federal and state statutes, regulations, and court decisions, which control the practice of pharmacy and drug distribution. Civil liability in pharmacy practice and elements of business and contract law will be covered. Lecture: two hours per week (hybrid).
PHA-506. Concepts in Infectious Disease
This course is offered to Fall semester to P3 students and is designed to allow students to explore and develop advanced knowledge and skills related to infectious diseases. This course will be of value to pharmacy students seeking careers in infectious diseases whether it be in ambulatory care pharmacy practice, community pharmacy, long-term care and population health management. Students will be heavily leading the course through presentations, cases and poster presentations. Active learning techniques are used throughout the course to build critical thinking and problem solving skills. Emphasis is placed on the integration of disease states and approaches to practice management. Assignments that engage students in lifelong learning and community engagement are additional features of the course.
PHA-509. Economic Evaluation of Pharmaceutical Products and Services
Introduction to commonly used economic evaluation methods (e.g., cost-minimization, cost-utility, cost-benefit, cost-effectiveness) as applied to pharmaceutical products and services. Quality of life and outcomes research will also be explored. Emphasis is on understanding evaluation methods and research design and interpreting the relevant literature for practice applications. Lecture: three hours per week.
PHA-510. General Medicine Advanced Pharmacy Practice Experience
Integration of the basic pharmacy related concepts to the delivery of pharmaceutical care in general medicine practice. Clinical practice: 40 hours per week for five to six weeks.
Successful completion P1-P3 curriculum in full.
PHA-511. Ambulatory Care Advanced Pharmacy Practice Experience
Integration of the basic pharmacy related concepts to the delivery of pharmaceutical care in ambulatory care settings. Clinical practice: 40 hours per week for five to six weeks.
Successful completion P1-P3 curriculum in full.
PHA-512. Community Advanced Pharmacy Practice Experience
Integration of the basic pharmacy related concepts to the delivery of pharmaceutical care in community practice settings. Clinical practice: 40 hours per week for five to six weeks.
Successful completion P1-P3 curriculum in full.
PHA-513. Health System Advanced Pharmacy Practice Experience
Integration of the basic pharmacy related concepts to the delivery of pharmaceutical care in the health system settings. Clinical practice: 40 hours per week for five to six weeks.
Successful completion P1-P3 curriculum in full.
PHA-515. Naplex Preparation
This course will be provided annually to P4 students to assist in preparation for The North American Pharmacist Licensure Examination (NAPLEX). Students will complete cumulative exams assigned by the coordinator.
PHA-521. Pharmacotherapeutics VII: Pulmonary Disorders*
This course is the 7th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of pulmonary diseases.
PHA-523. Pharmacotherapeutics VIII: Cardiovascular Disorders*
This course is the 8th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of cardiovascular diseases
PHA-525. Pharmacotherapeutics IX: Renal Disorders*
This course is the 9th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of renal diseases.
PHA-526. Pharmacotherapeutics X: Endocrine Disorders & Women's/Men's Health Issues*
This course is the 10th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of endocrine diseases.
PHA-528. Pharmacotherapeutics XI: Hematology/Oncology Diseases*
This course is the 12th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of gastrointestinal diseases.
PHA-530. Pharmacotherapeutics XII: Central Nervous System Disorders*
This course is the 11th of a twelve-module sequence that will integrate pharmacology, medicinal chemistry, pathophysiology and therapeutics. This team taught course is designed to provide students with an opportunity to learn, observe and apply concepts of these four content areas in an integrated manner. Concepts in each of these content areas will be emphasized to provide the necessary information for pharmaceutical management of CNS and mental health disorders.
PHA-532. Integrative Medicine and Nutrition
The purpose of the Integrative Medicine and Nutrition course is to help students learn to integrate nonconventional treatments (natural medicines, manipulation therapy, acupuncture, etc.) into traditional treatment strategies. Additionally, students will learn about nutrition support practices, including enteral and parenteral care.
PHA-534. Introduction to Hospital Pharmacy Practice
This course introduces students to the practice of pharmacy within a hospital setting. Topics discussed include the accreditation process for hospitals, career options and residency or fellowship training, medication formulary management, automation and technology in hospital pharmacies, medication calculations, medication safety, clinical pharmacy practice, and sterile product preparation.
PHA-536. Principles of Advanced Community Pharmacy Management
This course is designed to provide a foundation for students interested in pursuing the development and implementation of advanced clinical programs in a community pharmacy. The student will be introduced to principles in pharmacy and fiscal management, professional development, and the management and legal issues relating to clinical pharmacy services. Didactic and active learning techniques will be employed throughout the course and the student will be required to develop a business plan.
PHA-538. Pediatric Pharmacotherapy
This course is designed to expand the student’s current knowledge base regarding the pediatric population and to introduce the core concepts involved in the care of this special population. The course prepares students to identify and address drug-related problems in pediatric patients and to demonstrate competency within those areas. This will be accomplished by completion of case scenarios, actual patient presentations, and a take-home examination. An on-site visit to the Children’s Hospital of Philadelphia (CHOP) is required. Requirement: P-2 or P-3 standing.
PHA-540. Comprehensive Diabetes Management
This course provides a multidisciplinary foundation for health professionals in the principles of diabetes management. Students who successfully complete the course will have knowledge and the basic skill set that is needed to begin practicing diabetes management. The majority of this course is independent self-study of online lectures, but there are mandatory on-campus discussions and exams.Requirement: P2 or P-3 standing.
PHA-544. Managed Care Pharmacy
This elective is intended to help future pharmacists interested in any area of practice better understand the clinical and business decision-making processes of the health care system. The elective will introduce and reinforce the concepts of population health and value, explore tools available to limit healthcare spending, and discuss unique ways pharmacists can be involved in improving patient care. This course will be offered during the spring semester each year.
PHA-552. Principles of Bioorganic and Medicinal Chemistry
This will be an introductory course, the aims of which are to provide the principles of bioorganic and medical chemistry, including an understanding of drug structure-activity relationships, prediction of the physicochemical properties of a drug, basic knowledge of the major pathways of drug metabolism, and factors that can contribute to drug-drug interactions.
PHA-555. Introductory Pharmacy Practice Experience IV
The course is designed to provide an introductory practice experience at a P3 level in the areas of Medication Therapy Management (MTM)/clinical telepharmacy and Intergenerational (IG) patient care. The course fosters the development of knowledge, skills, and attitudes needed for pharmacy practice through practical application in telepharmacy patient care and community settings. |
PHA-556. Role of Phytochemicals on Health and Disease
Students will learn the basic concepts and classification of phytochemicals present in our daily diet, followed by the study of specific phytochemicals and their relation to human health and disease. Basic mechanisms and pathways through which phytochemicals act and alter will be discussed. Students will have an opportunity to gain an in-depth understanding of a specific phytochemical of their choice or any other phytochemical designated by the instructor through a research review paper and an in-class presentation.
PHA-558. Principles of Toxicology: From Beaker to Bedside
This toxicology elective is designed to provide the student with introductory knowledge
of the molecular mechanisms of action and clinical management of poisons. The course
will begin with introductory concepts such as history, mechanisms of cell injury and
toxicant disposition. The student will then be exposed to the fundamental principles
of managing an acutely poisoned patient. Toxicology lectures on each major organ
system will prepare students for group presentations. The aims of student presentations
will be to achieve a greater understanding of the clinical management of the poisoned
patient, and to hone presentation skills. To the extent that is feasible, the course
will involve lectures, or other learning experiences, led by external specialists.
The scope of poisons that will be discussed is broad, and includes environmental toxins,
industrial toxicants, and drugs. Specific agents will include heavy metals, volatile
solvents, common plant toxins, rodenticides, and several drugs. Students may be expected
to participate in one laboratory exercise, wherein they will learn a fundamental method
to characterize the mechanism and/or extent of cell death induced by a toxicant.
PHA-560. Self-Directed IPPE III
The Self-Directed (SD)-IPPE program is made up of three courses (SD-IPPE I, II, and
III) over the span of the Pl through P3 years. Collectively these courses consist
of a total of 20 hours of pharmacy-related, service-oriented learning.
The Self-Directed Introductory Pharmacy Practice Experience (SD- IPPE) course is designed
to expose students to various service-learning opportunities throughout their P 1
through P3 years. This experience consists of three components: participation in and
development of service- learning projects, reflection, and self-directed learning.
Students may develop their own experiences or participate in opportunities offered
by the School or professional organizations.
Requirements for service learning hours will increase as the student progresses through
the curriculum. Each student must complete a minimum of 2, 8, and 10 hours during
the Pl, P2, and P3 years, respectively (total 20 hours). Additional details are provided
in the SDIPPE syllabus conveniently posted in E*Value.
PHA-561. Principles of Environmental Health for Public Health Practice
Environmental health is concerned with the mechanisms by which the natural and created environment impact public health. The altered physical, chemical and biological systems will be presented from the perspectives of the population and community health. The course will focus on disease prevention, assessment and mitigation of environmental challenges to public health.
[[PHA 564]] Crosslisted with [[PHA 310]] or permission of instructor
PHA-562. Social and Behavioral Aspects of Public Health
Learners will develop public health competency in social concepts and processes that influence health status and public health interventions using the ecological approach. Targeted examination of population and individuals behaviors which influence health will utilize a range of methods necessary for behavioral change.
PHA-563. Public Health and Pharmacy
[[PHA 564]] Cross-listed with [[PHA 310]] or permission of instructor
PHA-564. Clinical Research and Design
PHA-599. A, B and C Elective Advanced Pharmacy Practice Experience Rotations
Advanced pharmacy practice experience involved in different aspects of pharmaceutical care. (Courses to be determined.) Clinical practice: 40 hours per week for a total of five weeks.
Successful completion P1-P3 curriculum in full.